Compare Bio Protocol (BIO) vs Neutron (NTRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Neutron — how do they compare? Bio Protocol trades at Rp440.44 (market cap Rp1T, Rp162,69M 24h volume), while Neutron trades at Rp25.52 (market cap Rp78,1M, Rp76,5M 24h volume). The key difference: Bio Protocol is far larger — about 12804.1× Neutron's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 804,1M / 999,7M NTRN (81%) for Neutron. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Neutron for 38 Days on average.
| BIO | NTRN | |
|---|---|---|
Market Cap | Rp1T | Rp78,1M |
Volume (24h) | Rp162,69M | Rp76,5M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 804,1M / 999,7M NTRN (81%) |
Typical Hold Time | 18 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Neutron (NTRN) shows limited market activity with a modest market cap of Rp78,1M and 81% circulating supply. The token exhibits minimal trading volume and network engagement, with no recent protocol updates or significant ecosystem developments. Technical indicators suggest low volatility and limited price movement due to thin liquidity.
Overall outlook remains cautious with major risks including extreme illiquidity, regulatory uncertainty, and lack of developer activity. Key opportunity exists only if the project gains meaningful adoption or exchange listings. Current holders face significant liquidity constraints with average hold time of 38 days.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Neutron
Neutron is the most secure cross-chain smart-contracting platform. It combines the security of a top 10 blockchain by staked capitalization with bleeding-edge cross-chain infrastructure to enable DeFi applications to securely scale across a growing network of 51+ interconnected blockchains.
Read more on NTRN →
